Institutional investors hold a majority ownership of TEVA through the 64.99% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $24.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 400.0 Thousand shares of Teva Pharmaceutical
TT INTERNATIONAL Bought 109.8 Thousand shares of Teva Pharmaceutical
PENN DAVIS MCFARLAND, INC. Bought 103.8 Thousand shares of Teva Pharmaceutical